Viking Therapeutics Inc Sustainability Reports
Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development of novel, orally available therapies for metabolic and endocrine disorders. The company's clinical programs include novel receptor agonists targeting conditions such as obesity, lipid disorders, and non-alcoholic steatohepatitis.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 529900IVC72YPFA25M37
FIGI: BBG006LGV887
5 reports from 2016 to 2024